Back Article

  • [1]

    Jing-Wei Zhang, Han Wang, Jing Liu, Le Ma, Rong-Hong Hua, Zhi-Gao Bu, 2021: Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors, Virologica Sinica, 36, 476-489. doi: 10.1007/s12250-020-00316-0

  • [2]

    Yu-Jia Shi, Jia-Qi Li, Hong-Qing Zhang, Cheng-Lin Deng, Qin-Xuan Zhu, Bo Zhang, Xiao-Dan Li, 2023: A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene, Virologica Sinica, 38, 585-594. doi: 10.1016/j.virs.2023.06.007

  • [3]

    Yuan Zhang, Chunjie Li, Xianliang Ke, Dan Luo, Yan Liu, Quanjiao Chen, Hanzhong Wang, Xiaohui Song, Zhenhua Zheng, 2022: Development of a biosensor assessing SARS-CoV-2 main protease proteolytic activity in living cells for antiviral drugs screening, Virologica Sinica, 37, 459-461. doi: 10.1016/j.virs.2022.04.002

  • [4]

    Leike Zhang, Jia Liu, Ruiyuan Cao, Mingyue Xu, Yan Wu, Weijuan Shang, Xi Wang, Huanyu Zhang, Xiaming Jiang, Yuan Sun, Hengrui Hu, Yufeng Li, Gang Zou, Min Zhang, Lei Zhao, Wei Li, Xiaojia Guo, Xiaomei Zhuang, Xing-Lou Yang, Zheng-Li Shi, Fei Deng, Zhihong Hu, Gengfu Xiao, Manli Wang, Wu Zhong, 2020: Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro, Virologica Sinica, 35, 776-784. doi: 10.1007/s12250-020-00288-1

  • [5]

    Xiaojing Wen, Li Zhang, Qiang Liu, Xinyue Xiao, Weijin Huang, Youchun Wang, 2022: Screening and identification of HTNVpv entry inhibitors with high-throughput pseudovirus-based chemiluminescence, Virologica Sinica, 37, 531-537. doi: 10.1016/j.virs.2022.04.015

  • [6]

    Yuhang Zhang, Zhenjiang Zhang, Fan Zhang, Jiwen Zhang, Jun Jiao, Min Hou, Nianchao Qian, Dongming Zhao, Xiaofeng Zheng, Xu Tan, 2023: ASFV transcription reporter screening system identifies ailanthone as a broad antiviral compound, Virologica Sinica, 38, 459-469. doi: 10.1016/j.virs.2023.03.004

  • [7]

    Robert William Figliozzi, Feng Chen, Albert Chi, Hsia Shao-Chung Victor, 2016: Using the inverse Poisson distribution to calculate multiplicity of infection and viral replication by a high-throughput fluorescent imaging system, Virologica Sinica, 31, 180-183. doi: 10.1007/s12250-015-3662-8

  • [8]

    Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 2022: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica, 37, 198-207. doi: 10.1016/j.virs.2022.01.029

  • [9]

    Ya-Nan Zhang, Yan-Ning Hu, Yu-Jia Lu, Xiao-Dan Li, Ana Carolina Gomes Jardim, Bo Zhang, 2026: Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Mayaro virus, Virologica Sinica, 41, 724-727. doi: 10.1016/j.virs.2026.06.012

  • [10]

    Qianran Wang, Lu Peng, Yanqiu Nie, Yanni Shu, Huajun Zhang, Zidan Song, Yufeng Li, Hengrui Hu, Liushuai Li, Xi Wang, Jia Liu, Jiang Li, Zhengli Shi, Fei Deng, Yu Guo, Yiwu Zhou, Bing Yan, Zhihong Hu, Manli Wang, 2023: Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo, Virologica Sinica, 38, 257-267. doi: 10.1016/j.virs.2022.12.007

  • [11]

    An-Kai Zhu, Sa-Sa Li, Shu-Pei Yu, Zhao-Yong Zhang, Huan Li, Jing-Feng Li, Shan-Shan Gao, Heng Chen, Jincun Zhao, Run Shi, Mingjian Lu, Chaoyang Li, 2022: A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis, Virologica Sinica, 37, 942-945. doi: 10.1016/j.virs.2022.10.003

  • [12]

    Yi Yan, Ke Wu, Jun Chen, Haizhou Liu, Yi Huang, Yong Zhang, Jin Xiong, Weipeng Quan, Xin Wu, Yu Liang, Kunlun He, Zhilong Jia, Depeng Wang, Di Liu, Hongping Wei, Jianjun Chen, 2021: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing, Virologica Sinica, 36, 901-912. doi: 10.1007/s12250-021-00378-8

  • [13]

    Weiyi Yu, Xianying Chen, Qiubing Chen, Peixuan Chen, Naizhang Liu, Yingjian Li, Xue Tan, Qiuhan Zhang, Yan Rao, Ming Guo, Zhixiang Huang, Xin Wang, Zhen Zhang, Wenjie Xiang, Yuzhen Zhang, Qianyun Liu, Hao Yin, Li Zhou, Yu Chen, Ke Lan, 2025: A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression, Virologica Sinica, 40, 793-803. doi: 10.1016/j.virs.2025.09.001

  • [14]

    Qiuyan Zhang, Na Li, Chenglin Deng, Zherui Zhang, Xiaodan Li, Kentaro Yoshii, Hanqing Ye, Bo Zhang, 2019: Trans Complementation of Replication-defective Omsk Hemorrhagic Fever Virus for Antiviral Study, Virologica Sinica, 34, 412-422. doi: 10.1007/s12250-019-00109-0

  • [15]

    Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo, 2021: A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery, Virologica Sinica, 36, 913-923. doi: 10.1007/s12250-021-00385-9

  • [16]

    Yuhan Gong, Junwen Liu, Wenxuan Ding, Yuxing Yan, Xue Hu, Gary Wong, Huaijie Jia, Zhengxiang Wang, Xin Li, Jiayi Chen, Xin Zhang, Chao Shan, Shuai Xu, Xiaoxia Wang, 2026: Antiviral activity of Saponin C from Liriope muscari against influenza A virus and SARS-CoV-2, Virologica Sinica, 41, 662-675. doi: 10.1016/j.virs.2026.06.002

  • [17]

    Mengyuan Chen, Shuizhen He, Hualong Xiong, Dongxu Zhang, Shaojuan Wang, Wangheng Hou, Xiaomei Zhu, Jin Wang, Yang Huang, Congming Hong, Yubin Wu, Ruoyao Qi, Tianying Zhang, Quan Yuan, Tingdong Li, Yixin Chen, Shiyin Zhang, Shengxiang Ge, Jun Zhang, Ningshao Xia, 2022: New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq, Virologica Sinica, 37, 758-761. doi: 10.1016/j.virs.2022.07.001

  • [18]

    Yi Yan, Ke Wu, Jun Chen, Haizhou Liu, Yi Huang, Yong Zhang, Jin Xiong, Weipeng Quan, Xin Wu, Yu Liang, Kunlun He, Zhilong Jia, Depeng Wang, Di Liu, Hongping Wei, Jianjun Chen, 2021: Correction to: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing, Virologica Sinica, 36, 1686-1687. doi: 10.1007/s12250-021-00465-w

  • [19]

    Danrong Shi, Keda Chen, Xiangyun Lu, Linfang Cheng, Tianhao Weng, Fumin Liu, Nanping Wu, Lanjuan Li, Hangping Yao, 2022: Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro, Virologica Sinica, 37, 295-298. doi: 10.1016/j.virs.2022.01.031

  • [20]

    Zhenwei Liu, Xingui Tian, Wenkuan Liu, Yuting Xian, Weilue Chen, Rong Zhou, 2021: A Sensitive and High-Throughput Flow Cytometry-Based Assay for Measuring Antibody Neutralization of Human Adenovirus Type 3, Virologica Sinica, 36, 537-544. doi: 10.1007/s12250-020-00295-2